Last 48 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.50 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.48 | 0.45 | 0.46 | 0.50 | 0.56 | 0.58 | 0.51 | 0.55 | 0.68 | 0.65 | 0.54 | 0.61 | 0.42 | 0.36 | 0.80 | 0.99 | 1.28 | 1.32 | 1.34 | 2.29 | 2.53 |
| — | -22.6% | -10.7% | -9.0% | -17.5% | -10.0% | -5.0% | -9.9% | +60.6% | +79.6% | -32.3% | -39.2% | -67.1% | -72.6% | -40.2% | -56.6% | -49.2% | -50.2% | -63.6% | -31.5% | -24.1% | |
| P/B Ratio | 0.85 | 0.89 | 1.00 | 0.92 | 0.95 | 1.09 | 0.95 | 0.91 | 1.25 | 1.24 | 1.02 | 0.98 | 0.62 | 0.53 | 0.97 | 1.02 | 1.52 | 1.58 | 1.55 | 2.06 | 2.09 |
| — | -18.8% | +5.0% | +1.9% | -23.9% | -11.9% | -7.2% | -7.9% | +99.6% | +136.3% | +5.2% | -3.6% | -58.9% | -66.8% | -37.2% | -50.4% | -27.1% | -37.1% | -61.5% | -37.0% | -26.0% | |
| P/FCF | — | — | 42.46 | — | — | 842.78 | 98.72 | — | — | 26.93 | 27.94 | — | — | — | — | — | — | — | 389.01 | — | 366.95 |
| — | — | -57.0% | — | — | +3029.9% | +253.4% | — | — | — | — | — | — | — | — | — | — | — | +1035.4% | — | +1453.7% | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 29.77 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +57.3% | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 47.6% | 44.1% | 45.5% | 49.1% | 50.4% | 50.8% | 44.8% | 44.2% | 45.3% | 46.5% | 48.1% | 44.1% | 37.1% | 40.2% | 40.7% | 42.6% | 33.5% | 40.6% | 44.7% | 43.5% | 50.5% |
| — | -13.3% | +1.6% | +11.0% | +11.3% | +9.2% | -6.9% | +0.3% | +22.1% | +15.7% | +18.3% | +3.4% | +10.9% | -1.0% | -9.0% | -2.2% | -33.8% | -20.7% | -9.7% | -5.1% | +9.7% | |
| Operating Margin | -8.7% | -20.2% | -5.4% | -9.9% | -11.4% | -7.7% | -6.6% | -9.3% | -14.2% | -8.8% | -8.0% | -20.9% | -38.2% | -55.6% | -14.1% | -30.4% | -66.4% | -9.8% | -2.8% | -16.9% | -8.7% |
| — | -162.1% | +19.3% | -6.3% | +19.9% | +12.2% | +16.5% | +55.4% | +62.8% | +84.2% | +43.4% | +31.3% | +42.5% | -469.8% | -405.8% | -79.7% | -660.2% | -242.6% | -124.2% | -589.1% | -17.0% | |
| Net Margin | -6.5% | -20.9% | -4.0% | -9.8% | -8.7% | -5.7% | -4.5% | -7.5% | -12.2% | -6.7% | -6.3% | -18.7% | -35.0% | -54.4% | -11.7% | -28.2% | -64.3% | -9.0% | -3.3% | -17.7% | -29.9% |
| — | -265.2% | +10.0% | -30.3% | +28.4% | +14.6% | +28.6% | +59.8% | +65.2% | +87.7% | +46.4% | +33.7% | +45.6% | -503.7% | -252.9% | -59.5% | -114.6% | -169.0% | -166.3% | -2000.0% | -332.6% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -12.4% | -9.7% | -2.2% | -4.4% | -3.7% | -2.7% | -2.1% | -3.3% | -5.4% | -3.2% | -2.9% | -7.3% | -12.2% | -18.1% | -3.5% | -7.0% | -17.5% | -2.7% | -1.0% | -3.9% | -6.0% |
| — | -264.8% | -3.0% | -33.6% | +32.6% | +16.5% | +29.1% | +54.8% | +55.5% | +82.3% | +16.6% | -4.5% | +30.2% | -573.1% | -267.0% | -80.2% | -190.5% | -184.1% | -168.6% | -1781.5% | -312.1% | |
| ROA | -7.6% | -5.9% | -1.3% | -2.8% | -2.4% | -1.7% | -1.3% | -2.0% | -3.2% | -1.9% | -1.8% | -4.5% | -7.9% | -12.7% | -2.6% | -5.1% | -12.9% | -2.0% | -0.7% | -2.9% | -4.6% |
| — | -243.2% | -0.7% | -39.4% | +27.3% | +11.8% | +25.2% | +55.0% | +59.1% | +84.8% | +30.8% | +11.7% | +38.8% | -529.4% | -254.8% | -74.6% | -183.6% | -184.0% | -169.6% | -1790.1% | -311.0% | |
| ROIC | -24.4% | -12.1% | -3.7% | -6.0% | -6.5% | -4.8% | -4.3% | -6.5% | -9.5% | -5.5% | -4.9% | -11.7% | -18.9% | -27.2% | -6.6% | -12.0% | -29.3% | -4.8% | -1.3% | -6.1% | -3.0% |
| — | -151.9% | +15.1% | +7.5% | +31.4% | +13.4% | +11.4% | +45.0% | +49.6% | +79.6% | +25.9% | +2.2% | +35.6% | -469.7% | -400.3% | -95.8% | -891.8% | -268.5% | -123.7% | -481.1% | -5.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.10 | 0.09 | 0.09 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.11 | 0.12 | 0.11 | 0.10 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 |
| — | +2.9% | -5.4% | -4.6% | -18.6% | -15.0% | -16.5% | -15.8% | +4.3% | +10.1% | +43.5% | +42.5% | +36.8% | +43.4% | +12.7% | +12.3% | +8.6% | -2.6% | -8.0% | +35.7% | +151.7% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8.47 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +403.3% | — | — | |
| Current Ratio | 3.12 | 2.96 | 2.74 | 3.10 | 3.12 | 3.14 | 3.03 | 3.07 | 2.42 | 2.66 | 2.70 | 2.70 | 2.86 | 3.73 | 4.53 | 4.47 | 4.66 | 4.83 | 5.32 | 5.32 | 5.35 |
| — | -5.5% | -9.5% | +1.2% | +29.1% | +17.9% | +12.2% | +13.8% | -15.3% | -28.7% | -40.5% | -39.7% | -38.7% | -22.8% | -14.7% | -16.0% | -12.9% | -13.7% | +0.4% | -4.7% | -0.7% | |
| Quick Ratio | 2.71 | 2.55 | 2.34 | 2.70 | 2.71 | 2.75 | 2.67 | 2.67 | 2.09 | 2.34 | 2.37 | 2.36 | 2.55 | 3.33 | 4.02 | 3.85 | 4.14 | 4.29 | 4.75 | 4.75 | 4.83 |
| — | -7.2% | -12.4% | +1.2% | +29.5% | +17.7% | +12.7% | +12.8% | -18.0% | -29.9% | -41.1% | -38.7% | -38.3% | -22.3% | -15.5% | -18.8% | -14.3% | -15.4% | -2.2% | -7.0% | -2.4% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying INGN stock.
Inogen, Inc.'s current P/E is -4.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Inogen, Inc.'s current operating margin is -8.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Inogen, Inc.'s business trajectory between earnings reports.